Trial Profile
Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 25 Jun 2020 Status changed from recruiting to discontinued due to enrollment difficulties compounded by the COVID pandemic.
- 05 Dec 2018 Status changed from not yet recruiting to recruiting.
- 26 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Aug 2018.